Aug 09, 2018 7:05am EDT IMV Inc. Reaches Multiple Milestones in Advanced Ovarian Cancer Clinical Trial
Jul 31, 2018 7:05am EDT IMV Inc. to Announce Second Quarter 2018 Financial Results and Host Earnings Call on August 8, 2018
Jun 03, 2018 10:57am EDT IMV Inc. (Formerly Immunovaccine Inc.) Presents New Positive Data From Phase 1b/2 Combination Clinical Trial in Advanced Ovarian Cancer at 2018 ASCO Meeting
May 30, 2018 4:35pm EDT IMV Leadership to Participate in Upcoming Investor and Business Development Conferences
May 25, 2018 4:05pm EDT IMV (Formerly Immunovaccine Inc.) to Present at the National Bank Financial Quebec Conference in Toronto
